Simon Pedder, Chief Executive Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 3,000 shares at $2.88 ($9K) on 2008-09-24, disclosed to the SEC on 2008-09-24.
Open-market purchase of $9k CHTP by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.88 | 1,300 | $4K | 43.0% |
| 2 | $2.89 | 200 | $578 | 6.6% |
| 3 | $2.93 | 1,500 | $4K | 50.4% |
| Total | $2.91 avg | 3,000 | $9K | 100% |
| Filing → |
| ATNX | BUY | 2018-11-14 | $30K | — | Filing → |
| ATNX | BUY | 2017-07-28 | $11K | — | Filing → |
| CLRB | BUY | 2014-08-22 | $50K | — | Filing → |